Endoscopy Procedures Estimates Market Outlook 2025 to 2035
The global endoscopy procedures estimates market was worth around USD 254 million in 2024 and is projected to expand at a noteworthy CAGR of 6.1% to reach USD 486 million by 2035.
The endoscopy procedures estimates report predicts greater market growth in the coming years, driven by factors such as increased demand for minimally invasive procedures, the rapid development of endoscopic technology, and rising numbers of gastrointestinal, respiratory, and urological disorders. As the focus on accurate diagnostics and timely disease detection intensifies, endoscopy procedures are emerging at the forefront of medicine.
The rising incidence of chronic ailments, including colorectal cancer (CRC), gastroesophageal reflux disease (GERD), inflammatory bowel diseases (IBD), and respiratory diseases (Upper & Lower), is stirring up the influx of advanced endoscopic technologies.
Also, enhanced imaging modalities, AI endoscopy, and robotic-assisted surgical approaches are all making strides in procedural accuracy and efficiency. Outpatient procedures are growing in popularity, and disposable endoscopes, which minimize the risks of infections, have also provided further room for growth in the market.
| Metric |
Value |
| Procedure Count in 2025 |
USD 269 Million |
| Procedure Count in 2035 |
USD 486 Million |
| Forecast CAGR (2025 to 2035) |
6.1% |
What are some of the key trends in the endoscopy precedures?
The growing trend for minimally invasive procedures over the forecast period act as a propelling factor. This drive has arisen due to the growing rate of disease incidence and the aging population, thereby expanding the customer base.
Minimally invasive procedures have many benefits to both the patient and the physician. They involve minor cuts (in contrast to open surgery) which works wonders in patient recovery, therefore being safer compared to open surgeries. Advantages include less blood loss, a shorter recovery period, lower risk of infection i.e. sepsis, and minimal surgical scars at the site of operation.
Endoscopy Procedures are particularly suited to minimally invasive procedures that reduce the risk of cross-contamination and transmission of infections involved in using reusable endoscopes. Minimally invasive procedures have a lesser recovery period, lower risk of inducing arterial fibrillation, and are much less time-consuming. This consumer-driven need is growing in the Endoscopy Procedures Estimates market.
Minimally invasive procedures can also lower the total costs of hospital care and treatment. Conventional surgery can lead to longer hospital stays, which are costly subsequently for both the patient and the health care provider.
Apart from that, it also propels the trends toward minimal invasive treatment-detecting disease in its nascent state. The disease is diagnosed early on and also for successful treatment with improved survival rates. By the use of endoscopy, various illnesses, from cancer to respiratory and gastrointestinal illnesses, can be identified.
The rising trend towards creating the demand for endoscopic procedures is expected to drive the growth of the increase in the Endoscopy Procedures Estimates market through the forecast period.
Opportunities in the Endoscopy Procedure Estimates
Colorectal and gastrointestinal diseases, such as CRC, IBD, and GERD, are on the rise globally. These diseases require regular monitoring and treatment, which frequently involve endoscopic procedures. Endoscopic procedures such as colonoscopies and upper gastrointestinal endoscopies are routinely carried out to diagnose and manage the disease at its early onset.
In certain instances, endoscopy procedures might be cheaper than employing reusable endoscopes. Because endoscopy Procedures are single-use and disposed of, cleaning and sterilization protocols are unnecessary.
According to the World Health Organization (WHO), more and more benign and malignant GI diseases and colorectal complications are diagnosed in older populations. According to the ASCO, approximately 147,950 adults will be diagnosed with colorectal cancer in the United States.
Stringent regulatory demands for sterilizing reusable endoscopes have boosted the use of Endoscopy Procedures. For the detection of cancer and tumors, both doctors and patients favor endoscopes because they can execute some of the safest and most efficacious procedures. This boosts the demand for endoscopes and drives the growth of the market.
Companies that invest in R&D can introduce market-ready products that are better, higher-performing, or safer than the competition. Goods developed at R&D collaborative facilities create machinery that exceeds the performance and safety standards of competitor products. Medigus disclosed its new product development to the world in 2020.
Disposable endoscope, the company asserts that its designed disposable endoscope moves efficiently during medical operations while keeping a distinctive shape that makes it highly affordable compared to reusable endoscopes.
Research and development investments lead to market growth of disposable endoscopes because they enable companies to develop modern technologies and products that meet healthcare provider requirements and final patient needs. The trend shows that R&D investments for various products will expand continuously before potentially extending across almost all future years.
Regional Analysis
North America holds the largest share of the market because of its high incidence of gastrointestinal diseases, advanced healthcare infrastructure, and robust regulatory environments that provide high-quality care.
The United States has the highest number of endoscopic procedures due to the extensive use of AI-based imaging and robotic surgical procedures. Public health initiatives for colorectal cancer screening and other preventive services further support market growth.
Europe has a considerable market share, led by improvements in diagnostic technologies and favorable reimbursement policies. Germany, France, and the United Kingdom are the primary markets, with high colorectal cancer screening rates and strong healthcare infrastructures. The growing emphasis on early disease detection and minimally invasive surgery is propelling demand for advanced endoscopic procedures.
The Asia-Pacific region is also expected to grow the fastest, driven by growing healthcare investments, a rapidly aging population, and growing awareness of early disease detection. China, Japan, and India are becoming key markets due to technological uptake and increased healthcare coverage. The rising incidence of gastric cancer and hepatobiliary diseases in these nations is also fueling the demand for innovative endoscopic solutions.
Shifts in the Endoscopy Procedures Estimates Market: 2020 to 2024 and Future Trends 2025 to 2035
The growing number of gastrointestinal diseases advances in minimal intervention procedures, and a slowly aging population that requires ordinary diagnostic and therapeutic procedures made the endoscopy procedure market grow significantly between 2020 and 2024.
Between 2025 and 2035, increased growth will be characterized by improved AI-assisted endoscopy, new robot-assisted procedures, and new diagnostic modalities such as capsule endoscopy and molecular imaging. AI in computer-aided polyp detection and real-time diagnosis shall improve procedural accuracy, enforcing stringent regulatory compliance and abolishing patient safety and infection control.
The market for endoscopy procedures will undergo radical changes in the next ten years, with many future advancements driven by AI, robots, and green initiatives. The rise in gastrointestinal, respiratory, and cancerous disease cases will further solidify the demand, while ongoing modification of the regulations would ensure better and safer procedural methods.
The global endoscopy procedures market is also expected to flourish hugely in the coming decade because of greater demand for minimum invasiveness of procedures along with the growing implementation of endoscopic technology in years to come with the rising rates of gastrointestinal disorders, respiratory illnesses, as well as urological conditions. Endoscopy is a crucial aspect when it comes to surgical and diagnostic procedures in various specialties such as gastroenterology, pulmonology, orthopedics, urology, and gynecology (OBGNY). The addition of artificial intelligence (AI)-aided diagnostics, high-definition imaging, and robotic-assisted endoscopy further transforms the practice and makes procedures more efficient and precise.
| Market Shift |
2020 to 2024 |
| Regulatory Landscape |
Compliance with standard infection control and device reprocessing guidelines. Stringent FDA and EU MDR regulations on endoscopic device safety. |
| Technological Advancements |
Widespread adoption of high-definition (HD) and narrow-band imaging (NBI) endoscopes. Increased use of disposable endoscopes for infection control. |
| Sustainability & Circular Economy |
Limited focus on sustainability. Reusable devices remain standard despite concerns over infection risks. |
| Production & Supply Chain |
Supply chain disruptions due to COVID-19 pandemic. Increased reliance on outsourcing manufacturing to Asia-Pacific regions. |
| Market Growth Drivers |
Increased awareness and adoption of endoscopic procedures for early disease detection. Rising healthcare expenditure globally. Demand for minimally invasive procedures. |
| Market Shift |
2025 to 2035 |
| Regulatory Landscape |
Expected regulatory evolution towards AI validation in endoscopy. Stricter guidelines for reprocessing and sterilization to prevent cross-contamination. |
| Technological Advancements |
AI-assisted endoscopy for automated polyp detection and diagnostic support. Increased use of robotic endoscopic surgery for complex procedures. Development of self-navigating capsule endoscopy. |
| Sustainability & Circular Economy |
Increased shift towards disposable and biodegradable endoscopes. Circular economy initiatives aimed at reducing medical waste from endoscopic procedures. |
| Production & Supply Chain |
More localized production of endoscopic devices to reduce dependence on overseas supply chains. AI-driven demand forecasting to optimize inventory and supply management. |
| Market Growth Drivers |
Integration of AI and robotics in endoscopy. Higher demand for outpatient and office-based endoscopic procedures. Emerging markets driving growth due to improved healthcare access. |
Country-wise Insights
The United States
The market is growing strongly in the United States because of an aging population, rising instances of colorectal cancer, and high adoption of newer endoscopic technologies. Encouraging reimbursement policies and huge investments in AI-driven endoscopy equipment are driving growth.
The USA market is driven mainly by the demand for laparoscopy, gastrointestinal (GI) endoscopy, and bronchoscopy. The market will show remarkable growth due to hospitals and ambulatory centers being key service providers.
South Korea
South Korea is witnessing a fast-developing market fueled by robust technological innovation and government policies favoring the growth of medical device development. South Korea is also becoming a medical tourism destination, with foreign patients traveling to avail high-quality, minimally invasive endoscopic procedures at reasonable prices. Rising trends in capsule endoscopy, and 4K and 8K imaging endoscopy solutions are determining the future of the South Korean market.
Japan
Japan is one of the most important markets for endoscopy procedures driven by early cancer screening, aging demographics, and government programs encouraging the local population to be aware of early diagnostics.
The need for advanced imaging endoscopy and computer-aided diagnostic devices is increasing, with local players like Olympus being the market leaders. Japan remains committed to investments in new endoscopic solutions, which makes it a significant hub for technological innovation in the field.
Key Insights
| Countries |
Attributes |
| The United States Procedure Count (2025) |
USD 25 Million |
| Soth Korea (CAGR) |
5.0% |
| Japan (CAGR) |
6.9% |
Category-wise Insights
Gastrointestinal (GI) Endoscopy Commands the Market as Digestive Disorders on the Rise
Gastrointestinal (GI) endoscopy commands the biggest market share owing to the increasing incidence of gastroesophageal reflux disease, inflammatory bowel diseases, & colorectal cancer. Major Applications are Colonoscopy, gastroscopy, and sigmoidoscopy. Population aging with subsequent increased colorectal cancer screenings.
Increasing use of capsule endoscopy for non-invasive diagnostics. Government guidelines recommend routine GI screenings. North America & Europe: High adoption rate due to well-established healthcare infrastructure and regular colorectal cancer screening programs. Asia-Pacific: High growth due to growing healthcare awareness and medical tourism.
Bronchoscopy Gaining Momentum with Increasing Cases of Respiratory Illnesses
The high demand for bronchoscopy is fueled by the high incidence of lung cancer and chronic obstructive pulmonary disease (COPD). Key Applications are tumor identification, lung infection diagnosis, & foreign body extraction.
Complications of bronchoscopy like bleeding and infections and Exorbitant costs of advanced bronchoscopic procedures. There is High demand in the United States & China due to growing pollution-induced lung diseases. In Europe, robust regulatory systems providing sophisticated bronchoscopy methods have been implemented.
Competitive Landscape
Key service providers in the endoscopy procedures estimates market are Vanguard Healthcare Solutions, Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Apollo Hospitals, Asan Medical Center, Singapore General Hospital, Mount Sinai Hospital, Cedars-Sinai Medical Center, Massachusetts General Hospital among others.
The endoscopy procedures market shows intense expansion because patients want minimally invasive procedures (MIS) and imaging technology develops while respiratory, gastrointestinal, and urological diseases become more common. Diagnostic endoscopy and therapeutic endoscopy form the two distinct market segments that serve pulmonology, gastroenterology, urology, orthopedics, and gynecology application areas.
The market expands because endoscopic devices undergo technical developments which include robotic-assisted endoscopy alongside artificial intelligence-integrated imaging systems. Higher numbers of elderly individuals lead to greater screening requirement demands because of the growing elderly population.
The healthcare industry is shifting towards outpatients and moving into ambulatory surgery centers (ASCs). The adoption rates are influenced by both policy updates from regulators and reimbursement policy adjustments. Intense market competition exists because key global companies continue to invest funds towards R&D and strategic partnerships as well as global territory development.
Estimated Range of Annual Endoscopy Procedures Market Share by the Top Service Providers
| Service Provider |
Estimated Annual Procedures Range |
| Top 5 Service Providers |
~35% - 50% |
| Tier II Players |
~15% - 25% |
| Others |
~25% - 50% |
The medical field of endoscopic procedures shows intense market competition which includes hospital chains that compete alongside ASCs and mobile healthcare groups. Procedural volume, adoption of technology, service quality, and geographical coverage propel competition.
Key Service Providers and Market Dynamics
The market leadership position belongs to Cleveland Clinic together with Mayo Clinic and Johns Hopkins Hospital through their esteemed history state-of-the-art facilities and board-certified experts. Medical organizations serving as endoscopy specialists deliver comprehensive examinations and surgical procedures to their patients who choose them first for complicated medical issues.
ASCs have gained increasing market competitiveness because they deliver cost-efficient care along with shorter wait times and specialize in performing endoscopic procedures on outpatients. The market penetration of Vanguard Healthcare Solutions along with other freestanding surgical centers grows through providing specialized services at prices below those of hospitals.
Asian healthcare clinics led by Apollo Hospitals (India) and Asan Medical Center (South Korea) together with Singapore General Hospital provide medical services to domestic residents alongside patients who travel for medical purposes. The service quality from these providers combines with cost savings to attract both international and local patients to their healthcare facilities.
Healthcare organizations that employ AI diagnostics alongside robotic endoscopies along with minimally invasive techniques gain stronger competitive positions. Medical institutions that implement contemporary technology acquire more patients while also enhancing the achievement rates of their procedures.
Key Strategies for Global Expansion
In medical tourism and global patient care Apollo Hospitals (India), Asan Medical Center (South Korea), and Singapore General Hospital utilize efficient and high-quality healthcare services to transfer patients from expensive USA and European territories. These medical facilities have started offering high-tech endoscopy procedures at competitive prices which leads patients to choose medical tourist destinations.
The healthcare leaders Cleveland Clinic together with Mayo Clinic and Johns Hopkins Hospital increase their market share by developing strategic partnerships. Through Cleveland Clinic Abu Dhabi, patients access the identical high-end endoscopic care that exists in the USA treatment facility located in the Middle East region.
The healthcare providers target their business expansion into burgeoning markets across Asia-Pacific Latin America and the Middle East due to growing healthcare investments combined with elevated demand for diagnostic testing. Through mobile endoscopy units, Vanguard Healthcare Solutions addresses underprivileged communities to provide better access to healthcare facilities.
Technology-Driven Market Penetration: Telemedicine along with robotic-assisted procedures combined with AI-assisted endoscopy allows providers to scale their business activity without needing physical presence. Massachusetts General Hospital together with Mount Sinai Hospital began using AI algorithms in endoscopic examinations so patients now require fewer face-to-face medical appointments.
Key Attributes and Offerings by Company
| Service Provider |
Key Attributes |
| Cleveland Clinic |
High procedural volume, research-driven, advanced technology |
| Mayo Clinic |
Multispecialty expertise, AI-assisted diagnostics, global reputation |
| Johns Hopkins Hospital |
Strong academic research, advanced endoscopy unit, robotic-assisted procedures |
| Apollo Hospitals |
Leading Asian provider, cost-effective, strong medical tourism presence |
| Vanguard Healthcare Solutions |
Mobile healthcare services, flexibility in deployment |
| Service Provider |
Core Offerings |
| Cleveland Clinic |
Gastrointestinal, bronchoscopy, endoscopic ultrasound (EUS), capsule endoscopy |
| Mayo Clinic |
Upper GI endoscopy, colonoscopy, ERCP, interventional endoscopy |
| Johns Hopkins Hospital |
Therapeutic endoscopy, bariatric endoscopy, laser endoscopy |
| Apollo Hospitals |
Diagnostic & therapeutic endoscopy, GI motility studies, endoscopic variceal banding |
| Vanguard Healthcare Solutions |
Mobile endoscopy units, temporary hospital staffing, outpatient endoscopic services |
Fact.MR has provided detailed information about key players of Endoscopy Procedurres Estimates market positioned across regions, offerings, and speculative technological expansion, in the recently published report.
